STERIS plc (STE) Stock Forecast
STE analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.22 / 5 from 9 analysts
- Price target
- $259.17 average of analyst targets
- Upside to target
- +16.4% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $2.67
- 52-week range
- $199.40 – $268.65
STE analyst ratings
9 analystsNumber of analysts at each rating.
STE price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
STE earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.68 | $2.66 | $2.70 | $2.47 | +8.4% | 5 |
| Next quarter (Dec '26) | $2.80 | $2.77 | $2.82 | $2.53 | +10.8% | 5 |
| Current fiscal year (FY2027) | $11.17 | $10.90 | $11.29 | $10.17 | +9.9% | 7 |
| Next fiscal year (FY2028) | $12.28 | $12.04 | $12.59 | $11.17 | +9.9% | 7 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
STE revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.56B | $1.56B | $1.58B | +7.2% | 6 |
| Next quarter (Dec '26) | $1.61B | $1.59B | $1.62B | +7.5% | 6 |
| Current fiscal year (FY2027) | $6.37B | $6.35B | $6.39B | +7.3% | 6 |
| Next fiscal year (FY2028) | $6.77B | $6.68B | $6.82B | +6.3% | 6 |
STE EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
STE revenue: reported and forecast
STE EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.70 | $2.68 | $2.68 | $2.68 | $2.68 | −0.7% | 0 up · 2 down |
| Next quarter (Dec '26) | $2.81 | $2.81 | $2.81 | $2.81 | $2.80 | −0.4% | 0 up · 4 down |
| Current fiscal year (FY2027) | $11.16 | $11.17 | $11.17 | $11.17 | $11.17 | +0.1% | 5 up · 1 down |
| Next fiscal year (FY2028) | $12.18 | $12.25 | $12.25 | $12.25 | $12.28 | +0.8% | 6 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
STE earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; STE beat in 11 of 12.
What analysts expect from STE
9 analysts cover Steris; their consensus rating is buy (4.22 on a 1–5 scale, where 5 is a strong buy). The average price target is $259.17, 16.4% above the latest close of $222.66. Analysts expect earnings of $11.17 per share for FY2027, +9.9% from a year earlier. For FY2028 the average estimate is $12.28 per share on revenue of $6.8 billion. Steris beat the EPS estimate in 11 of the last 12 quarters.
Related: STE income statement, STE key metrics, STE chart. See the STE stock overview for the latest quote and news.
STE forecast FAQ
What is Steris's price target?
The average analyst price target for Steris is $259.17, 16.4% above the latest close of $222.66.
Is Steris a buy, hold or sell?
Of 9 analysts covering Steris, 4 rate it a strong buy, 3 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Steris's EPS forecast?
Analysts forecast $11.17 per share for FY2027 (range $10.90 to $11.29); for FY2028 the estimate is $12.28.
What is Steris's revenue forecast?
The average revenue estimate for FY2027 is $6.4 billion, growth of 7.3%; for FY2028 it is $6.8 billion.
When does Steris report earnings?
Steris is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $2.67.
Does Steris usually beat earnings estimates?
Steris reported EPS at or above the analyst estimate in 11 of the last 12 quarters.